
IQVIA Hlds (IQV) Stock Forecast & Price Target
IQVIA Hlds (IQV) Analyst Ratings
Bulls say
IQVIA Holdings reported notable year-over-year growth in several key areas, including Full-Service Provider (FSP), Real World Evidence (RWE), and Contract Sales Management Services (CSMS), contributing to an optimistic outlook for the company's performance. The company is experiencing positive momentum in its commercial segment, facilitated by improved client decision timelines and a robust pipeline, primarily driven by recent drug launches. Moreover, IQVIA's confidence in achieving a growth rate exceeding 4% for its Research and Development Solutions (R&D) segment on a constant currency basis, along with an improved pricing environment, further underpins a strong financial outlook.
Bears say
The financial analysis highlights several fundamental concerns regarding IQVIA Holdings' outlook. The company experienced a notable decline in year-over-year constant currency (YOY CC) growth, which fell to 3.8% in 3Q25 from 6.8% in the previous quarter, signaling a potential slowdown amid challenging comparisons from the previous year. Additionally, the concern surrounding rising interest rates poses a risk to earnings, as the company's floating/fixed rate mix may face increased pressure, impacting overall profitability and margin performance.
This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.
IQVIA Hlds (IQV) Analyst Forecast & Price Prediction
Start investing in IQVIA Hlds (IQV)
Order type
Buy in
Order amount
Est. shares
0 shares